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Abstract
The recent development of high-resolution DNA microarrays, in which hundreds of thousands of single nucleotide
polymorphisms (SNPs) are genotyped, enables the rapid identification of susceptibility genes for complex diseases. Clusters
of these SNPs may show runs of homozygosity (ROHs) that can be analyzed for association with disease. An analysis of
patients whose parents were first cousins enables the search for autozygous segments in their offspring. Here, using the
AffymetrixH Genome-Wide Human SNP Array 5.0 to determine ROHs, we genotyped 9 individuals with schizophrenia (SCZ)
whose parents were first cousins. We identified overlapping ROHs on chromosomes 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 16, 17,
19, 20, and 21 in at least 3 individuals. Only the locus on chromosome 5 has been reported previously. The ROHs on
chromosome 5q23.3–q31.1 include the candidate genes histidine triad nucleotide binding protein 1 (HINT1) and acyl-CoA
synthetase long-chain family member 6 (ACSL6). Other overlapping ROHs may contain novel rare recessive variants that
affect SCZ specifically in our samples, given the highly heterozygous nature of SCZ. Analysis of patients whose parents are
first cousins may provide new insights for the genetic analysis of psychiatric diseases.
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Introduction
Schizophrenia (SCZ) is categorized as a severe chronic
debilitating psychosis that affects approximately 1% of the global
population. Although genetic factors are reported to contribute to
the disease and multiple responsible loci have been identified from
linkage analysis and case-control association studies, there have
been few reproducible results to date [1].
Morrow et al. (2008) [2] suggested that homozygosity mapping
is a powerful tool not only for investigating single gene defects but
also for rare genomic variants in complex traits. They observed
homozygous deletions in patients with autistic disorders and
concluded that genomic alterations might be a subset of disease-
causing mutations in chromosomal regions. The increased
susceptibility to SCZ observed in consanguineous families suggests
that genomic recessive variations may be involved in its etiology.
[3–5] Considering this and other results, we hypothesized that
homozygosity mapping, including identical by descent (IBD)
analysis, would be a highly constructive method for identifying
the loci responsible for SCZ.
We hypothesized that runs of homozygosity (ROHs) could
contribute to SCZ by a recessive effect. We use the term ‘‘ROH’’
[6] instead of loss of heterozygosity (LOH) for regions where
homozygous genotypes are contiguous because LOH implies
heterozygous deletions or hemizygosity, while ROH suggests consec-
utive homozygous regions. Recessive effects are obtained by genetic
variations including single nucleotide variations, small insertions/
deletions, structural variations, and chromosomal rearrangements.
These variations may affect amino acid sequences or the control of
gene expression, including small RNA expression.
Here, we describe a homozygosity mapping strategy that consisted
of 2 stages (Figure 1). The firststage aimed to find the appropriate size
threshold for autosomal ROHs that would distinguish ROHs
specifically existing in the offspring of first-cousin marriages from
those that commonly exist in the offspring of non-consanguineous
marriages. By comparing the size distribution of ROHs between the
offspring of first-cousin marriages and non-consanguineous marriag-
es, we concluded that ROHs .2.1 Mb in size in the offspring of
consanguineous marriages can be assumed to be IBD segments from
an individual 3 generations before. The second stage aimed to find
shared ROHs among patient with SCZ using 2 models. In Model I,
an autosomal ROH size threshold was applied to filter out smaller
ROHs. Larger ROHs were assessed to find overlaps among the
patients. In Model II, after filtering by the ROH size threshold,
ROHs shared by the siblings of patients and ROHs of other patients
were assessed to find overlaps. The overlapping ROHs we identified
potentially contain SCZ causative regions that are specific to our
samples because of the heterogeneous nature of SCZ.
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1. Samples
A total of 9 subjects with SCZ (3 males and 6 females, aged 31–
56 years) (SCZ individuals) were recruited to this study after being
diagnosed as having typical paranoid schizophrenia by a certified
psychiatrist (N.K.) using the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision (DSM-IV-TR) and the
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). The
study received ethics approval from the Committee for Ethical
Issues on Human Genome and Gene Analysis at Nagasaki
University, Japan. All of the patients were from the main islands of
Japan, excluding Okinawa. We obtained written informed consent
from all participants. The consanguineous patients were from 8
first-cousin marriages. Seven individuals (patients a to g) were
unrelated and 2 were siblings (patients h-1 and h-2). We also
recruited 92 healthy individuals from non-consanguineous mar-
riages (non-CJ individuals) from the main islands of Japan,
excluding Okinawa. We confirmed consanguinity by interview.
We did not match for gender in the SCZ and non-CJ individuals
because we only intended to analyze autosomal chromosomes.
After obtaining written informed consent, genomic DNA was
isolated from peripheral blood. We did not collect blood samples
from the patients’ parents, except for 1 patient, or siblings;
however, we confirmed that they had no history of psychiatric
illness, with the exception of the older brother of patient g, by
direct interview or from the medical records of the other related
individuals.
Furthermore, we also assessed the International HapMap Project
[7] phase 3 data of the Japanese in Tokyo (HapMap3 JPT) to
evaluatethenon-CJ individuals.Rawsignalintensityfiles(CELfiles)
obtained using Affymetrix Genome-Wide Human SNP Array 6.0
(Affy6.0) were downloaded from http://www.hapmap.org/.
2. Microarray analysis
We performed genome-wide SNP genotyping of 9 SCZ samples
and 92 non-CJ samples using the Affymetrix Genome-Wide
Human SNP Array 5.0 (Affy5.0) according to the manufacturer’s
instructions. Our microarray data is MIAME compliant and the
raw data has been deposited in the CIBEX database (CIBEX
accession number: CBX141).
3. ROH detection
We generated the CHP genotype files from the CEL signal
intensity files using the BRLMM-P genotype calling program
[8,9]. For the detection of ROHs, we analyzed the CHP files with
a hidden Markov model (HMM)-based ROH detection function of
the PartekH Genomics Suite (Partek GS) software version 6.5 build
6.11.0207 (Partek, St. Louis, MO, USA). We applied the following
default HMM parameters: max probability=0.99, genomic
decay=0 (disabled), genotype error=0.01, and default frequen-
cy=0.3. We did not adopt the baseline files.
Detected ROHs were statistically analyzed and visualized
(Figures 2 and 3; Tables 1 and 2) by using in-house scripts written
in the R language [10]. The optimization of histogram bandwidths
and the estimation of the probability density distributions were
performed using the ‘‘KernSmooth’’ package of R [11].
Furthermore, to validate the data quality of our non-CJ
samples, we also compared our data to HapMap3 JPT. Affy6.0
raw signal intensity data in CEL files were subjected to allele
calling using Birdseed software version 2 [12]. SNP genotypes of
shared loci between Affy6.0 and Affy5.0 were extracted and
processed as well as the non-CJ and SCZ datasets to detect ROHs.
4. Detection of potential genetic loci for SCZ by
overlapping ROHs
To detect the overlapping ROHs among the SCZ dataset, the
identified ROHs were filtered by a size threshold on Partek GS,
Figure 1. Two-stage design of this study. A, the first stage was to
find an appropriate autosomal run of homozygosity (ROH) size
threshold to distinguish specific ROHs from the offspring of first-cousin
marriages from ROHs in the offspring of non-consanguineous
marriages. The size distribution of ROHs in our non-consanguineous
Japanese (non-CJ) and schizophrenia (SCZ) samples was compared.
Non-CJ samples are the offspring of non-consanguineous marriages
that were validated by interview. Here, SCZ samples were used as the
offspring of first-cousin marriages regardless of phenotype. Samples
from parents were not used in this study (dashed squares and circles).
To confirm our strategy, we also assessed HapMap3 JPT samples, which
do not have information for phenotypes or family consanguinity
(dashed and solid lines between parents). B, the second stage was to
find shared ROHs among the SCZ samples as patients with
schizophrenia. In Model I, an autosomal ROH size threshold was
applied to filter out smaller ROHs (dashed open boxes). Larger ROHs
(solid open boxes) were assessed to find overlaps among patients (solid
boxes). In Model II, after filtering by the ROH size threshold, ROHs
shared by the siblings of patients and ROHs of other patients were
assessed to find overlaps. In this study, the gender of the samples was
not matched (diamonds) because we only evaluated autosomal ROHs.
doi:10.1371/journal.pone.0020589.g001
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generate a table of overlapping ROHs, and visualized with Partek
GS. Then, we extracted the loci shared among more than 3
unrelated individuals (Model I) (Table S1). Furthermore, on the
basis of the hypothesis that concordant sibling cases share causal
loci, we detected the loci shared among 2 sibling cases (h-1 and h-
2) (Model II) and found the ROHs that were shared by 1 or more
of the unrelated samples (Table 3).
Results
1. Determination of the ROH size threshold
discriminating the offspring from non-consanguineous
and first-cousin marriages
We genotyped 440 794 SNPs in each individual. Genotype
calling rates for each sample ranged from 97.23–98.83% and their
call rates were high and accurate enough for their subsequent
evaluation. We utilized the data from 92 non-CJ and 91
HapMap3 JPT samples in addition to the data from 9 SCZ
individuals.
Our homozygosity mapping strategy utilized differences in the
length distribution of ROHs between offspring from consanguin-
eous and non-consanguineous marriages. Individuals from con-
sanguineous families are expected to have an increased number of
longer ROHs containing autozygous segments. These segments
were also expected to be discriminated by their length from ROHs
containing homozygous segments by chance or by linkage
disequilibrium (LD). To demonstrate the strategy, we performed
detailed comparisons of the length distribution of ROHs between
the non-CJ, HapMap3 JPT, and SCZ datasets.
We initially plotted the total number and size of ROHs in the
non-CJ, HapMap3 JPT, and SCZ datasets (Figure 2). The non-CJ
and HapMap3 JPT datasets clustered together, except for 3
individuals in HapMap JPT. These 3 outlier individuals,
NA18987, NA18992 [13], and NA19012 [14], have been assumed
to be from consanguineous families; indeed, the distribution of
these samples was similar to that of our offspring from first-cousin
marriages (Figure 2).
We then analyzed the length distribution of ROHs in the non-
CJ and SCZ datasets. Bar plot histograms of the length of ROHs
were obtained and the probability density curves were estimated
by the ‘‘KernSmooth’’ package in R (Figure 3A–D). Descriptive
statistics of these plots are also shown in Table 1. Both datasets
produced bell curve-like distributions in the log10 scale on the x-
axis to indicate the length of each ROH; however, the SCZ
dataset showed a secondary peak in the larger ROH region. We
expected that the autozygous region from the founders of the third
ancestral generation (great-grandparents) would be larger in the
SCZ dataset than in the non-CJ dataset, in whom LD may
encompass ROHs by chance. The proportion of larger ROHs in
the SCZ dataset was clearly higher than in the non-CJ dataset. As
we can expect that 1/16 of the whole genome in the offspring of
first-cousin marriages would be autozygous regions from their
great-grandparents, we highlighted the graphs in Figure 3B and
Figure 2. Distribution of the size and number of individual autosomal runs of homozygosity (ROHs). Sums and total numbers of
individual ROHs are shown by circles and triangles indicating unrelated Japanese individuals (non-CJ: 92 samples) and the offspring of first-cousin
marriages with schizophrenia (SCZ: 9 samples), respectively.
doi:10.1371/journal.pone.0020589.g002
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20589Figure 3. Size distribution of autosomal runs of homozygosity (ROHs). In the size distribution plot of non-consanguineous Japanese (non-
CJ; A and B) and schizophrenia (SCZ; C and D) samples, the x-axis indicates the ROH size (log10 scale). A and C, individual average frequency of the
ROHs as histograms. B and D, estimated probability density corresponding to each histogram. Black areas shows 1/16 (6.25%) of autosomes, which is
equivalent to the expected sum of autozygous regions in the offspring of a first-cousin marriage. E, enlarged overlap of B (gray) and D (hatched). F,
SCZ/non-CJ odds ratio plot. X-axis indicates the size of the ROHs (log10 scale). Y-axis (log10 scale) indicates the ratio of areas exceeding the given ROH
size threshold in the estimated probability distributions of the SCZ and non-CJ datasets.
doi:10.1371/journal.pone.0020589.g003
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the ROH distribution reaches 179.2 Mb, which is 1/16 of the
2 867 732 772 bases total size of the autosomal haploid genome,
according to the statistics from the NCBI Build 36.1 assembly
(2006) [16]. This analysis suggested that it is highly probable that
the longer ROHs would be inherited from the great-grandparents;
however, it should be mentioned that genomic regions with less
recombination tend to have longer ROHs.
To show further differences in the probability density
distribution of the SCZ and non-CJ individuals, we also plotted
an SCZ/non-CJ odds ratio (OR) plot (Figure 3F and Table 2),
which indicates the ratio of probability for the existence of ROHs
in each dataset over a given threshold length. To determine the
overlapping ROH regions shared among the SCZ dataset, we
adopted OR=3.0 and the corresponding threshold of 2 137 962
bases to ensure practical power and to detect smaller IBD regions
by recombination.
2. Determination of potential SCZ genetic loci by
overlapping ROHs
The sum lengths of the overlapping regions among 0–7
independent family patients are shown in Figure 4, and the
calculated percentage sum length among a given number of
patients and more in the autosomal genome were as follows:
100%, 51.7%, 13.6%, 6.0%, 1.9%, 1.3%, and 0.6%. Considering
the statistics, we adopted a minimum of 3 patients for identifying
candidate loci. Figure 5 shows a schema of the overlapping ROHs
within autosomes and their positions are summarized in Table S1.
Overlapping ROHs found in 3 or more SCZ individuals on
chromosomes 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 16, 17, 19, 20,
and 21 (Figure 5A) suggested that many loci are potentially
associated with SCZ in our patients. Only the locus on
chromosome 5 has been reported in a previous linkage analysis
of SCZ [16]. The ROHs were expanded by the analysis of 4
additional individuals; however, no additional loci were detected
(data not shown). The locus on chromosome 5q23.3–q31.1
included the regions containing the histidine triad nucleotide
binding protein 1 (HINT1) and acyl-CoA synthetase long-chain
family member 6 (ACSL6) genes. Our results suggest that recessive
variants of these candidate genes could be involved in the
pathogenesis of SCZ in our patients.
In the analysis of 2 siblings (h-1 and h-2) from a first-cousin
marriage, we searched for the ROH regions shared by the siblings
as a single gene defect. The detection of loci shared by the siblings
and 1 or more unrelated individuals demonstrated ROHs on
chromosomes 1, 5, 7, 8, 10, 12, 13, 16, 17, 19, and 21 that might
be causative for SCZ (Figure 5B). Those loci did not include any
previously reported candidate genes. Interestingly, among the loci
detected in Figure 5A and 5B, there were no overlapping loci
identified in this study.
Table 1. Autosomal runs of homozygosity (ROHs) size distribution, where descriptive statistics of ROH sizes were detected with
Partek GS.
Dataset N Minimum
a Mode
b Maximum
c Average sum
d
HM3JPT
e 88 19 750 (14) 256 499 (27) 32 000 000 (1252) 831 159 144
non-CJ
f 92 18 160 (14) 248 288 (27) 32 250 000 (1921) 859 784 793
SCZ
g 9 27 380 (14) 258 488 (38) 57 810 000 (9896) 956 266 858
aMinimum ROH size in all individuals from each dataset.
bMode ROH size in all individuals from each dataset.
cMaximum ROH size in all individuals from each dataset.
dAverage sum is the average total ROH size per individual from each dataset.
eThe International HapMap Project phase 3 Japanese in Tokyo. Three samples, NA18987, NA18992, and NA19012, of 91 samples are omitted because they are
potentially the offspring of a consanguineous marriage.
fNon-consanguineous Japanese.
gSchizophrenia.
Numbers are in bases, and the numbers in parentheses are the included probe sets.
doi:10.1371/journal.pone.0020589.t001
Table 2. Thresholds, individual average sums of runs of homozygosity (ROHs), its ratio in the autosomal genome, and the
individual average encompassed number of ROHs corresponding to the odds ratios.
Odds ratio Threshold (base) Non-CJ
a dataset SCZ
b dataset
sum (base)
Autosomal
ratio (%)
# of
ROHs sum (base)
Autosomal
ratio (%) # of ROHs
1.3 1 000 000 185 411 092 6.5 93.2 420 200 807 14.7 123.6
2.0
00
1 548 817 110 468 918 3.9 30.6 341 258 405 11.9 52.7
3.0 2 137 962 81 383 855 2.8 13.8 309 296 125 10.8 33.8
4.0 3 630 781 65 633 075 2.3 7.6 288 028 919 10.0 25.4
5.0 5 128 614 53 423 627 1.9 4.7 263 695 116 9.2 19.8
10.0 24 547 089 7 925 263 0.3 0.3 85 167 811 3.0 2.7
aNon-consanguineous Japanese.
bSchizophrenia.
doi:10.1371/journal.pone.0020589.t002
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1. Samples
We recruited 9 offspring from first-cousin marriages (SCZ) and 92
from non-consanguineousmarriages(non-CJ).Asshown inFigure 2,
our non-CJ dataset and publicly available HapMap3 JPT datasets
showed a common cluster, except for the presence of 3 outliers that
have been reported to be potentially from consanguineous families
[14,15]. This concordance suggests that our experimental quality
and data processing approaches were appropriate. In this study, we
analyzed a limited number of samples; however, homozygosity
mapping was a reasonable strategy to adopt because it requires
relatively smaller number of samples than case-control studies. We
did not use samples from the parents of patients in this study because
these are not very informative in our strategy. On the other hand,
affected and unaffected siblings in single families are strongly
informative in homozygosity mapping, and we are continuously
recruiting additional siblings for future study.
2. ROH analysis
Most of the previous homozygosity mapping studies were based
on genotypes derived from microsatellites or simple tandem-repeat
polymorphisms (STRP). The highly polymorphic nature of multi-
allelic STRP markers is suitable to cover the whole genome with a
fewer numbers of markers. However, recent DNA microarray
technologies have enabled massive genome-wide SNP genotyping
to be performed in a short time. The problem with homozygosity
mapping based on SNPs is the accurate detection of regions with
ROHs. As SNPs have a less informative biallelic nature, using the
naı ¨ve definition of an ROH as just a contiguous homozygous region
may skew the detection of ROHs because of the frequency of low
minor allele SNPs, genotyping errors, and ‘‘no-call’’ SNPs.
The solution to this problem using the Affymetrix Human
Genotyping 500K arrays and Illumina Infinium HumanHap300v2
arrays was the application of ROH detection bins sliding through
each chromosome to filter out low SNP density bins and to allow the
small number of heterozygous SNPs and no-call SNPsto be placed in
a bin [6,17]. An alternative method to detect ROHs is to adopt an
HMM. Partek GS software implements the HMM-based ‘‘LOH
detection’’ algorithm. A similar algorithm is also implemented in the
Affymetrix GeneChip Chromosome Copy Number Analysis Tool
(CNAT), as described in the CNAT user guide [18]. The HMM-
based algorithm of these tools takes not only the information of
adjacent SNP genotypes but also the heterozygosity of SNPs as a
reference baseline calculated from the genotyping results in the
reference samples or the ap r i o r idefault frequency. This method is
expected to more accurately detect ROH regions that reflect actual
recombination.
Selection of the reference population for the baseline data is
crucial for the HMM-based detection of ROHs. If the reference
population is carefully selected to match the background of the
case population, the baseline generated from the observation of
actual SNPs in the reference population can omit ROHs resulting
from LD and regions with low SNP density, such as centromeres.
However, if strict matching of the used population background is
difficult, use of the fixed default heterozygous frequency, whose
Table 3. Novel loci identified in this study that are different from those in Table S1, for the segments overlapping in more than 1
unrelated individual and the common regions between the 2 siblings (cases h-1 and h-2).
Chromosome Start End Samples # Samples
a Length Cytoband
1 146258078 148749860 h-1, h-2, a 3 2491783 1q21.1-q21.2
5 45437574 49631829 h-1, h-2, d 3 4194256 5p12-q11.1
5 117360252 120214932 h-1, h-2, f 3 2854681 5q23.1
5 120214932 122586267 h-1, h-2, f, g 4 2371336 5q23.1-23.2
7 57594442 62282881 h-1, h-2, b, f 4 4688440 7p11.2-q11.21
8 129121122 131617749 h-1, h-2, b 3 2496628 8q24.21-q24.22
8 132434559 139244531 h-1, h-2, b 3 6809973 8q24.22-24.23
10 37363792 37599485 h-1, h-2, e 3 235694 10p11.21
10 37599485 37874740 h-1, h-2, e, g 4 275256 10p11.21
10 37874740 42217616 h-1, h-2, c, e, g 5 4342877 10p11.21-q11.21
12 33982292 36255461 h-1, h-2, a, d 4 2273170 12p11.1-q11
13 35366458 43580724 h-1, h-2, g 3 8214267 13q13.3-14.11
16 28924029 29606107 h-1, h-2, c 3 682079 16p11.2
16 29606107 29657036 h-1, h-2, c, f 4 50930 16p11.2
16 29657036 29680943 h-1, h-2, c, d, f 5 23908 16p11.2
16 29680943 31277953 h-1, h-2, b, c, d, f 6 1597011 16p11.2
16 34467305 34647935 h-1, h-2, a, b, c, d, f, g 8 180631 16p11.1
16 34647935 45122807 h-1, h-2, a, c, d, f, g 7 10474873 16p11.1-q11.2
16 45122807 47094922 h-1, h-2, a, b, c, d, f, g 8 1972116 16q11.2-q12.1
17 29659797 32811528 h-1, h-2, a 3 3151732 17q12
19 37676724 40349191 h-1, h-2, a 3 2672468 19q13.11-13.12
21 19821557 20188026 h-1, h-2, g 3 366470 21q21.2
aNumber of individuals (including h-1 and h-2) who shared the region; for example, 5 indicates that 3 other individuals shared the common region of the 2 siblings.
doi:10.1371/journal.pone.0020589.t003
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negatives in the detection of ROHs.
To determine the optimal length threshold of ROHs to extract
autozygous segments from whole ROHs, we adopted OR=3 for
the analysis. This approach may work well when a large enough
reference sample is available. When a reference population is not
available, a threshold where the sum of the ROH length in the
upper tail of its distribution is equal to the theoretical autozygous
length of a genome, that is, 1/16 of a genome in the offspring of a
first-cousin marriage, could be another option. In our SCZ
dataset, the threshold using this approach was approximately
10.6 Mb.
Our results demonstrated obvious differences in the proportion
of the length distribution of ROHs between the non-CJ and SCZ
datasets. A recent report on European populations, including
endogamy subpopulations, has shown that a higher proportion of
individuals in endogamy subpopulations have ROHs longer than
1.5 Mb compared with other subpopulations [6]. Our scatter plot
of the individual total number and size of ROHs (Figure 2) is not
fully in agreement with this previous report, although the non-CJ
dataset made a cluster and showed a positive correlation (Pearson
product-moment correlation coefficient r=0.773), and the SCZ
dataset was scattered and showed a weak positive correlation
(r=0.432). This may be explained by the fact that the previous
report excluded ROHs ,500 kb to ignore ROHs that potentially
resulted from LD and removed hemizygous deletions of ROHs. In
this study, we did not adopt a strategy to filter ROHs by their size
before the analyses because the discrimination of autozygous
regions and LD simply by size is essentially impossible. Adopting a
baseline file derived from a strictly matched population in the
HMM-based detection of ROHs can be used instead. Addition-
ally, differences in genotyping platforms with different SNP
densities may affect the size distribution of ROHs. Although our
data from the sparser Affymetrix Genotyping 10k SNP panel
produced a similar bell curve-like ROH size distribution, the
whole curve was shifted to the right (data not shown).
The size distribution of ROHs for a given population is affected
by its inbreeding coefficient (F). Studies of consanguineous
marriages in subpopulations from Japan during the 1980s
compared the F values for Japan (F=0.00134) to those in Kuwait
(F=0.0219), India (F=0.02313), England (F=0.00017), and the
United States (F=0.00003) [19,20]. These reports have also
shown that despite the decrease in consanguineous marriages in
Japan, local subpopulations have higher F-values. The same
tendency has also been shown by a genealogical study that
estimated inbreeding rates in large and semi-isolated populations
on the basis of historical changes in population size [21]. Recently,
the importance of studying endogamous populations has been
stressed [22]; however, populations with intermediate F-values
have advantages for our homozygosity mapping approach. This
approach uses the differences in the size distribution of ROHs in a
case population consisting of offspring from consanguineous
marriages and a control population consisting of offspring from
non-consanguineous marriages. A high F-value population may
not have clear distribution differences between cases and controls.
On the other hand, finding a sufficient number of cases in low F-
value populations may not be easy. From this standpoint, an
intermediate F-value population, such as the Japanese population,
Figure 4. Sum of run of homozygosity (ROH) lengths and number of overlapping patients, excluding patient siblings. Y-axis indicates
the sum of ROH lengths shared by a given number of patients. The zero column indicates the sum of ROHs not shared by any of the samples.
doi:10.1371/journal.pone.0020589.g004
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approach, as was shown previously in the Costa Rican population
[23,24].
We presented here some threshold lengths of ROHs to detect
IBD regions from great-grandparents. As recombination will, of
course, occur everywhere by chance, small autozygous regions
could be overlooked with the threshold shown here. However, no
systematic analyses have so far identified IBD regions in
consanguineous marriages by whole-genome SNP typing. Our
method shown here, which 1) detects longer ROHs in each
individual and 2) aligns ROHs and identifies overlapping regions,
will be helpful for autosomal recessive disorders and also for
complex disorders resulting from rare variants. If collecting
patients in geographically and historically isolated areas is possible,
this homozygosity mapping approach is likely to be successful.
Nonetheless, the effectiveness of homozygosity mapping for
complex disorders remains controversial [4]. We believe that we
can uncover new candidate loci through the application of whole-
genome SNP typing to homozygosity mapping because of its high
density genomic coverage and high-throughput ability.
3. Possible novel loci for schizophrenia
We identified several putative SCZ loci that are presented in
Figure 5 and Tables S1 and 3. In our study, we assumed the 2
models outlined in the Methods section. Model I was designed to
find shared causal loci among unrelated individuals. For the other
model, we hypothesized that the siblings shared the same causal
loci; thus, Model II was designed to find the common loci between
the siblings and unrelated individuals.
For Model I (Table S1), from the analysis of 7 unrelated
individuals, the loci included the 5q23.3–q31.1 region that was
previously identified by linkage analysis in the Irish population
[16]. Among the genes that mapped to 5q23.3–q31.1, HINT1
[25,26] and ACSL6 [27] were previously reported to be possibly
associated with SCZ. In patients from consanguineous families we
analyzed, homozygous genomic variations may be causative for
the disease (Figure 5 and Tables S1 and 3). However, small sample
size in our study may be a limiting factor to generalize such
conclusions. In common diseases such as psychiatric disorders,
including SCZ and bipolar disorders, especially in familial cases or
in cases from relatively isolated areas, rare variants possibly
contribute more than common variants to the disease phenotype
[28–30].
On the basis of the rare variant-common disease hypothesis, it is
appropriate that the genetic etiology between sibling cases and
other unrelated cases may be various. In addition, our results
suggested that multiple loci influenced the susceptibility to SCZ, as
other reports have suggested [31].
We presented here the systematic analyses of the homozygosity
mapping method using whole genome SNP typing, and we
identified ROHs that potentially contain SCZ causative recessive
regions that are shared among our samples. When we explain SCZ
as a result of the homozygous state of rare variant mutations, the
number of overlapping individuals may be challenging, as it is
possible that each individual has a different variation. The
heterogeneity of SCZ may explain the lack of overlap for our
results with previously reported regions [32,33]; moreover, our
methodology has a limitation for detecting causative genes that are
included in shorter ROHs by chance. We have shown that the
Affymetrix Genome-Wide Human SNP Array 5.0 or 6.0 could be
applied to special cases including first-cousin marriages to identify
genomic variations. Increasing number of samples obtained from
patients from consanguineous families with SCZ is important to
make our results more meaningful. Furthermore, we plan to
analyze genetic variants in updated ROHs by the next-generation
sequencing technologies.
Supporting Information
Table S1 Novel loci identified in this study.
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